MCM
AEON icon

MAI Capital Management’s AEON Biopharma AEON Stock Holding History

MAI Capital Management’s Portfolio AEON Stock Details AEON Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$58 Hold
58
– – ﹤0.01% 4846
2025
Q4 		$64 Hold
58
– – ﹤0.01% 4210
2025
Q3 		$47 Hold
58
– – ﹤0.01% 3764
2025
Q2 		$45 Hold
58
– – ﹤0.01% 3917
2025
Q1 		$34 Sell
58
-1
-2% -$7 ﹤0.01% 3397
2024
Q4 		$2.29K Buy
+59
New +$3.44K ﹤0.01% 2999

Other funds holding AEON

DIG
Dauntless Investment Group Etna, New Hampshire $151M AUM 76.14% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BOCH
Blue Owl Capital Holdings New York $372M AUM 78.25% 1-Year Est. Return
FAM
Formidable Asset Management Cincinnati, Ohio $629M AUM 15.56% 1-Year Est. Return
XT
XTX Topco George Town, Cayman Islands $5.75B AUM 30.56% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM
LPL Financial
LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

MAI Capital Management's AEON Position: Q1 2026 in Review

MAI Capital Management held its AEON Biopharma (AEON) position steady in Q1 2026 at 58 shares worth $58. The position accounts for ﹤0.01% of the portfolio, ranked #4846.

MAI Capital Management first reported a position in AEON in Q4 2024 and has held it in 6 quarters since. The position peaked at $2.29K in Q4 2024. 24 funds tracked by Wall St. Rank hold AEON as of Q1 2026.

  • MAI Capital Management held 58 shares of AEON Biopharma worth $58 as of Q1 2026.
  • MAI Capital Management left its AEON Biopharma share count unchanged in Q1 2026.
  • AEON Biopharma made up ﹤0.01% of MAI Capital Management's portfolio in Q1 2026, its #4846 holding.
  • MAI Capital Management first reported a position in AEON Biopharma in Q4 2024 and has held it in 6 quarters since.
  • MAI Capital Management's AEON Biopharma position peaked at $2.29K in Q4 2024.
  • 24 funds tracked by Wall St. Rank held AEON Biopharma as of Q1 2026.

Based on MAI Capital Management's 13F filing for Q1 2026, filed 15 May 2026.